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Introduction
Infection is a devastating, costly, and challenging complication
following totalhiparthroplasty (THA),withan incidenceof1 to
2% and 3 to 4% in primary and revision cases, respectively.1–4
It’s very important for every orthopedic surgeon to know
how to recognize and consequently to treat this complication.
In 2011, the Musculoskeletal Infection Society and the
Center for Disease Control convened a work group to formu-
late a definition for periprosthetic joint infection (PJI).5
They defined that PJI can be diagnosed if one of these
major criteria is present:
• Presence of a sinus tract communicating with the
prosthesis.
• Isolation of a pathogen via culture from two separated
tissues or fluid samples or if four or more of the minor
criteria are present:
 Raised erythrocyte sedimentation rate (ESR).
 Elevated synovial white blood cell count.
 Elevated synovial polymorphonuclear leukocytes
(PMN) percentage.
 Purulent fluid in the affected joint.
 A pathogen isolated from one specimen of peripros-
thetic tissue or fluid.
More than five PMNs per high power fieldmicroscopy
in five high power fields.
Infections can be divided in acute (<4 weeks) and chronic
(>4 weeks). Chronic infections are more frequent, and two-
stage revision is considered gold standard.6 In literature, also
single-stage revision and irrigation and debridement are
reported as valid treatments; while Girdlestone resection
arthroplasty, arthrodesis, and amputation are nowadays
only rescue procedures to be considered in few selected
patients.
Microbiology: Which Bacteria Affect the
THA?
Different bacteria are involved in PJI. To treat the infection, it
is important to recognize the pathogen agent. PJI typically
occurs as a result of bacteria inoculation during surgery,
contiguous spread of infection from an adjacent site, or









Abstract Infection after total hip arthroplasty (THA) is a devastating complication with signifi-
cant consequences for patients. In literature, single and two-stage revision, irrigation
and debridement, Girdlestone resection arthroplasty, and arthrodesis and amputation
are reported as possible treatments. Recently, two-stage revision has become popular
as the gold standard treatment for chronic hip joint infections after THA. In this review,
we evaluate the current literature about microbiology of periprosthetic joint infections
and the use of antibiotic-loaded cement spacers. We aim to give an overview about
indications, clinical results, and mechanical complications for spacers implantation,
evaluating also selection criteria, pharmacokinetic properties, and systemic safety of
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far away from the hip. Obviously, infection prevention is
fundamental. Illingworth et al7 have recently defined a
correct pre and postoperativemanagement. They underlined
the importance of Staphylococcus aureus as pathogen agent.
This gram-positive bacterium had a prevalence of coloniza-
tion of 32.4% in 2001 to 2004: this percentage decreased to
28.6% thanks to decolonization protocols that include com-
binations of mupirocin nasal ointment application, chlor-
hexidinemouth rinse, and chlorhexidine bodywash for up to
5 days preceding surgery. Staphylococcus is for sure the most
frequent bacteria causing a PJI, due to its intrinsic capability
to adhere to biofilm and to solid matrix.
Biofilm is made of polysaccharides, proteins, and extracel-
lular DNA. It protects bacteria by antimicrobial drugs and host
immune system making infection treatment very difficult.8
The low drugs susceptibility of bacteria covered by biofilm
is derived by a low growth rate and presence of resistant
bacterial subpopulations.9 Furthermore, the presence of bio-
film causes delays in diagnosis limiting culture’s sensitivity.
Between the most frequent etiological agents (in addition
to S. aureus) we have to consider the negative coagulase
staphylococci, especially the Staphylococcus epidermidis.10
This agent has a high virulence due to its capability to adhere
to prosthetic material.
Analyzing some studies, published in the past 5 years
and extrapolating the epidemiological data reported
in ►Table 1, 11–18 we noticed how the incidence of Staphylo-
coccus infection is the most frequent attending for almost 70%
of thecases. Similar results are reportedbyTandeandPatel that
reviewed 14 studies with a total of 2,400 patients.19 Strepto-
coccus are less involved, even if Streptococcus agalactiae has to
be mentioned. Streptococcus is a gram-positive bacteria char-
acterized by the presence of wall antigens B. It is often present
in the infection of the urogenital apparatus in women, and its
involvement in PJI is a negative prognostic factor.20
Two-Stage Revision Surgical Technique
Asmentioned before, it is the gold standard treatment for PJI.
It is divided into two different stages.
The first one consists of the prosthesis removal, sample
collection for histology/microbiology and spacer placement;
meanwhile the second one consists of spacer and cement
removal, sample collection for histology/microbiology, and
new implant selection and placement.
During the first stage, the joint exposure should be
performed on the original incision.
Accurate debridement of fibrous and necrotic tissue is
mandatory.
Antibiotics prophylaxis should not be started until three
to six microbiological samples are taken.20,21 Then the
prosthetic components have to be removed taking attention
to avoid any damage to the bone, which could be fragile.
While removing the acetabular component the surgeon
should pay attention to avoid the creation of segmental
defects on the acetabular rim that can potentially determine
subsequent spacer instability. Removal of the prosthetic
stem can be complex, especially if cemented fixation was
used. A complete series of blades and chisels must be
available in the operating room.
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Whena stemiswellfixed, transferal osteotomyorextended
trochanteric osteotomy may be needed to remove the stem.
Unfortunately, these procedures have high complication
rate.22,23
Recently Chen et al24 considered the potential serious
damages that the surgeon can causeby removing awell-fixed
component. Due to this reason, they have assessed the
possibility of partially removing previous components. In
this study, the well-secured prosthetic components were
retained from 16 patients. At the end of a 5-year follow-up,
81.3% of the patients were free of infection.
All removedcomponents canundergo sonication, but in the
literature, there are conflicting opinions about its efficacy.20
The next phase consists of proceeding with the placement
of the antibiotic-loaded spacer that can be handmade,
molded, or prefabricated. The antibiotics to be mixed with
cement should be chosen based on the exams held by the
surgeon such as microbiological analysis of articular fluid
obtained during hospitalization. Once the spacer has been
fixed, a careful hemostasismust be performed and a drainage
should be positioned to avoid postoperative hematomas.
During postoperative time, it is extremely important that
the patient is followed by a multispecialist team. The patient
mustbeeducatedand trained tomaintain aproperpartial load
and retrieving the mobilization or dislocation of the device.25
An adequate antibiotic therapy should be indicated by an
infectious disease specialist and should be continued for
approximately 6 weeks.5,20 At the end of the antibiotic
therapy, patient is left antibiotics-free for about 2 weeks,
and then is re-evaluated. A multispecialist consensus is
needed to proceed to the second stage.
In the second stage we consider different steps: approach
(made to the joint through the previous surgical scar), spacer
and cement removal, sample collection for histology/microbi-
ology, and new implant selection and placement.
The removal of spacer and cement will likely cause an
additional loss of bone stock that have to beminimized. After
copious pulsating washes, to remove any residual piece of
cement that can be a source of reinfection, the optimum
implant (that can be cemented or uncemented) is selected.
The optimum management of bone loss, prosthetic design,
and fixation must be preoperatively planned to achieve a
stable implant.
Antibiotic-Loaded Bone Cement
Two-stage revision has two main targets: preserving soft
tissue balancing (this is made possible thanks to the spacer)
and defeat infection, delivering high local antibiotic dose.
The second one is achieved by the use of antibiotic-loaded
bone cement (ALBC) with the help of systemic administration.
Nowadays cement can be blended with a manual mixing
procedure or can be premixed in during the production of
powder. Unfortunately, not every antibiotic is usable.
Anagnostakos and Kelm26 have defined some desirable
characteristics like: availability in powder form, wide antibac-
terial spectrum, bactericidal at low concentrations, elution
frompolymethylmethacrylate (PMMA) in high concentrations
for prolonged periods, thermal stability, low or no risk of
allergy or delayed hypersensitivity, low influence on the
mechanical properties of the cement, and low serum protein
binding.
The same authors underlined that aminoglycosides and
glycopeptides are the two groups of antibiotics that fulfill
most of these criteria. Gentamicin and vancomycin are very
popular in combination thanks to the availability of pre-
mixed gentamicin ALBCs and to the antistaphylococcal ac-
tivity and thermal stability of vancomycin.27 Dose of
antibiotic andwayof preparation can affect cementmechan-
ical properties.
First of all, we have to differ between prophylaxis, that
requires low doses of antibiotic(s) (usually 1g antibiotic(s)/
40g PMMA), and treatment ofmusculoskeletal infections, that
requires higher doses (usually 4 g antibiotics/40 g PMMA).26
Unfortunately, the addition of high doses of gentamicin
powder (>4g antibiotics/40g PMMA) decreases the compres-
sive strengthof the cement. The sameeffect canbeobtainedby
mixing liquid antibiotics (for example in hand mixing prepa-
rations).28 It is demonstrated that increasing dose of gentami-
cin in bone cement reduces shear stress strength, predisposing
the cement to crack nucleation in case of prolonged dynamic
loading.29 Similar loosening of mechanical strength can be
obtained mixing liquid gentamycin.30
It is easy to imagine how such a large variability of options
can modify mechanical properties in many different ways.
The mixing method affects homogeneity of the microscopic
particles and has to be considered.31,32 It is reasonable to
think that the premixed cements have a greater homogeneity
due to the industrial process even though some studies
report a similar homogeneity between the premixed prod-
ucts compared with the hand mixed ones.33
Recent studies in the literature analyzed mechanical
resistance to fatigue of antibiotics-loaded cements hand
mixed versus premixed ones. DeLuise and Scott34 have
compared a hand-mixing generic tobramycin (Pharma-Tek,
Huntington, New York, United States) into Simplex P against
commercially prepared tobramycin-loaded bone cement
(Simplex with Tobramycin; Stryker Orthopaedics). They
came to the results that the hand mixing cement suffered
a 36% decrease. These findings differ with those of previous
studies.
Like what happens for strength properties, even elution is
influenced by the type of antibiotic, composition, mixing
method, etc.
It is very important, to have a complete eradication, that
the spacer releases antibiotic constantly above the minimal
inhibitory concentrations (MICs) of the causative organism
(s) until the prosthesis reimplantation.
Masri et al35 measured the intra-articular antibiotic con-
centrations during postsurgery days. At day 1, tobramycin
and vancomycin concentrations were 107 μg/mL and 19 μg/
mL, respectively. These concentrations were 10 to 30 times
higher than the MICs of the infecting organisms. The same
authors found that increasing tobramycin dose may enhance
both antibiotics elution but for vancomycin the increment
was not the same.
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Hsieh et al36 reported on the elution of vancomycin and
aztreonam. In this study, the vancomycin peak concentra-
tions were initially 1,538μg/mL and fell after 7 days to a
mean value of 519μg/mL.
Anagnostakos et al37 determined the elution of gentamicin
andvancomycincollectedfromthedrainagefluidduringatwo-
stage protocol. They founda peakconcentration for gentamicin
derived from spacers of 21.15μg/mL, and 37.0μg/mL for van-
comycin on day 1. At last determination, the concentrations
were respectively 1.85μg/mL for gentamicin and 6.60μg/mL
for vancomycin after 7 days.
Boelch et al38 measured gentamicin and vancomycin
concentrations derived by different antibiotic-loaded
cements for 6 weeks. They analyzed PALACOS R (Heraeus.
Hanau, Germany) (antibiotic free), PALACOS RþG (Heraeus.
Hanau, Germany), COPAL GþV (Heraeus. Hanau, Germany),
and COPAL GþC (Heraeus. Hanau, Germany). They use
PALACOS R (Pal) as control group. The test groups were
PALACOS RþG with premixed gentamicin (PalG), COPAL
GþV with premixed gentamicinþvancomycin (CopV), PAL-
ACOS RþG manually blended with vancomycin (PalV), and
COPAL GþC containing premixed gentamicinþ clindamycin
(CopC). The last one resulted to have significantly higher
gentamicin concentrations than all the other formulations
while for vancomycin antibiotic-loaded cements, after
12 hours, PalV produced significantly higher concentrations
than premixed one. The authors affirmed that the elution
from premixed gentamicin is independent of the loading
technique with vancomycin while manual blending with
vancomycin leads to a higher vancomycin elution at the
expense of compressive strength properties.38
Similar findings are exposed by Anagnostakos and
Meyer39 in a recent systematic review. Authors underlined
that antibiotics in powder form have a lower impact on the
mechanical properties of bone cementwhereas antibiotics in
liquid form improve pharmacokinetic properties, but they
have negative impact on the mechanical stability reducing
the compressive strength of bone cement by 49% and the
tensile strength by 46%. The authors also suggest to prevent
the weight bearing on the operated leg until the prosthesis
reimplantation if liquid antibiotics are used.
A recent consensus defined that the best antibiotic must to
be tailored for each patient based on the organism profile and
patient’s comorbidities. However, most infections can be
treatedwith a spacerwithvancomycin (1–4g per 40g package
of cement) associated with gentamicin or tobramycin (2.4–
4.8g per 40g package of cement).40
Despite the effort of several authors, which antibiotic is
better to choose for treatment and which ALBC is mechani-
cally superior remain unanswered questions and require
additional studies.28
Antibiotic-loaded spacers can locally deliver high antibi-
otic concentrations that may exceed the systemic adminis-
tration and for this reason can cause systemic toxicity and
allergic reactions. Cases of acute renal failure, hepatic failure,
bone marrow depression caused by ALBC are described in
literature.41–43 Exceptionally Wentworth et al44 reported
one case of dermatologic reaction in 135 hip spacer implan-
tation group. The pathogenesis is not well known, it is
advisable for surgeon to monitor possible skin reactions
and laboratory parameters during hospital stay.
Spacers
The spacer system is an important step in the two-stage
revision technique.
Its purpose is to maintain the tension of soft tissues,
guarantee the continuous local release of antibiotics, and
reduce hematoma formation.
Spacers are classified into two major categories: static or
dynamic. Dynamic ones allowan earliermobilization and,with
regard to the hip joint, they are the majority. They can also be
classified according to the manufacturing method in hand
made, molded, and prefabricated. Handmade spacers have
the peculiarity of being able to adapt to different needs which
the surgeon may encounter during surgery. They are usually
reinforcedwithSteinman’spins toguaranteegreater resistance.
However, the most used are certainly molded and
prefabricated.
Molded spacers arebuilt directly in theoperating roomwith
theaidofa specialmold inwhich theantibioticcement selected
is cast; they can be reinforcedwith hip stents or Steinman’s pin
that are embedded in the mold before the cement is poured.
According to Faschingbauer et al45 the use of Steinman’s wires
reduces from50to13%of the rateofmechanical complications,
hypothesis confirmed by Jung et al25 who assert that the
insertion of a metallic endoskeleton into antibiotic cement is
a protective factor against breakage of spacer.
Ben-Lulu et al17 have described a singular spacer, after
extended trochanteric osteotomy, constituted by a molded
antibiotic-loaded spacer reinforced by metal endoskeleton
assembled and pressmounted in a precut reamed intramedul-
lary nailfilledwith ALBC to bypass the distal end of osteotomy.
Prefabricated spacers are premade by industry and are
available in different sizes. They have a load-bearing struc-
ture in stainless steel coatedwith antibiotic bone cement and
resemble a femoral prosthesis. These characteristics are
really appreciated by surgeons.
These spacers allow a good articulation and load in the
postoperative but, as being temporary solutions they have
the disadvantage of being available in limited sizes that do
not always fit the patient’s characteristics.
After surgery patients are usually allowed partial weight-
bearing with crutches. It is advisable that physiotherapist
takes patients in charge from the first postoperative day.25
Usually after spacer implantation a tailored antibiotic therapy
must be settled up by an infectious disease specialist. This
therapymustconsider intraoperativecultures resultsandhave
to be continued for a long time, approximately 4 to 6 weeks.
Thedecision toproceedwith thesecondstage isdeterminedby
negative cultures of a hip aspirate performed 4 weeks after
discontinuation of the antibiotics and reduction of inflamma-
tory markers (ESR <30mm/h and CRp <10mg/L).46
We reviewed 14 articles found in literature12–18,47–53
published in the past 10 years for a total of 7,912 patients.
Data are collected and reported in ►Table 2.
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Infection resolution rates results are quite satisfactory
reaching approximately 90% but the procedure is not out of
risks, in fact instability rates averaged around 8 to 10%.
Information collected were (whenever reported) the type
of implanted spacers, their functional result, the Girdlestone
procedure rate, and the time of retention of the spacer. The
average retention timeof a spacer is approximately5months,
though there are studies that reported a shorter time.25
Results obtained from literature are more than flattering
and pave the path for a more aggressive treatment of PJI
following THA. Patients who undergo surgery are by defini-
tion fragile patients.
Cancienne et al48 reported that 60% of the patients treated
for PJI go throughsecondstagewhile 16.8% retained thespacer.
Similar data are reported by Gomez et al16: in this study
87 patients of 178 did not receive prosthesis reimplantation:
6.9% were amputated, 5.7% received resection arthroplasty
according to Girdlestone, 4.6% were subjected to arthrodesis,
and 82.8% maintained the spacer. The authors point out that
in reality the success rate is less than 90% sincemanypatients
died between first and second stage. Obviously, a higher rate
of success of the spacer retaining increases the rate of
complications.16,54,55 Starting from the studies alreadymen-
tioned in►Table 2 and integrating themwith others present
in literature we summarized the rates of the most common
complications in ►Table 3.12,14,17,18,45,47,50,55
It has to be noticed that the rate of complications is
definitely higher for Petis et al55 than for the other studies
that we compared. This can be attributed to the fact that in
this study exclusively prolonged retention spacers were
considered. Except for this study it can be highlighted that
the complication rate fluctuates between 10 and 20%.
Dislocation is the most frequent complication found in
literature: its incidence is 8.46% in all 567 included patients.
These results reflect those reported by Faschingbauer et al.45
In literature, very heterogeneous rates ranging from 10 to
over 40% are reported.25,56–58 Unlike Koo et al, Takahira et al
and Shin et al41,59,60 did not observe any dislocation follow-
ing the implantation of standardized spacers.
There aremany variables that come into play in the case of
dislocation: first of all, the type of spacers (handmade,
molded, or prefabricated) and its geometry, the head/neck
ratio, femoral fixation type, mismatch between spacer head
and acetabular diameter, hypotrophy of surrounding
muscles, previous surgical interventions and type of surgical
approach, poor bone quality, patient compliance, education
and maintenance of the physiotherapeutic path.
Thefirst authors trying to identify themainrisk factorswere
Leuniget al.57Their studyshows that theneck tohead ratiowas
significantly higher in dislocating spacers (0.960.19) than in
those not-dislocating spacers (0.760.05).
Another factor that can be associated with failure was an
insufficient deep anchorage in the intramedullary canal; in
fact, the complication-free spacers were on average deepened
in femoral canal for 5741mm,while the failure groupswere
deepened for only 2233mm.
Spacer’s fractures are the second complication by the
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approximately 10% of the cases, ranging in literature from 10
to 15%.25,61 For preventing spacer’s fractures some studies
suggest the reinforcement with Steinmann’s pins, intrame-
dullary nails, or prostheses.
Kummer et al62 reported as spacerswith prostheses and the
commercial spacers did not fail at 3,000N while those rein-
forcedwith pins failed at 832Nand thosewith nails at 1,275N.
Thielen et al63 studied in vitro the mechanical stability of
spacers reinforced with endoskeleton compared with non-
reinforced spacers. Nonreinforced spacers failed at 400 to
600N while rod-reinforced spacers failed at 1,000 to 1,300N.
“Full-stem” reinforced spacers failed at different forces that
ranged from 2,380 to 4,311N depending on the thickness of
endoskeleton. For Jung et al,25 there are no clinical data for
demonstrating that metallic endoskeleton improves the me-
chanical properties, unlike what is sanctioned by Faschingba-
uer et al.45 Moreover, Jung et al25 underlined the fact that it is
still unclear whether the use of endoskeleton has adverse
effects on the pharmacokinetic properties of the spacer.
We do not have to forget the risk of periprosthetic
fractures, facilitated by concomitant osteoporosis and poor
bone-stock derived from infection and previous implant
removal and debridement procedures.
Conclusion
Treatment of chronic hip joint infections after THA is a
challenging problem. Two-stage revision arthroplasty with
the use of antibiotic-loaded spacers is the gold standard and
permits an infection rate control over 90%.
The use of spacers provides a lot of advantages like main-
taining limb length, joint mobility, and partial weight bearing.
The major complications are dislocation and spacer’s
rupture. Actually, the best antibiotic and mixing association
(antibiotic and dose) is still debated.
A multimodal approach is necessary to increase success
rate in treating these cases. A team composed by orthopedic
surgeon, physical therapist, and infectious disease specialist
must be created to take advantage of their combined skills
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